Results

• All
• Video
• Audio
• Images

• Most recent

1–2 of 2 results for DPP-4 inhibitors

• 

  Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

  Andrew J. Barkmeier, MD

  Annual Meeting Talks

  2024

• 

  Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

  Andrew J. Barkmeier, MD

  Updates from the Field

  2024